Studies of fondaparinux in patients with renal dysfunction: PK [pharmacokinetic] study of fondaparinux in outpatients with renal dysfunction.

Trial Profile

Studies of fondaparinux in patients with renal dysfunction: PK [pharmacokinetic] study of fondaparinux in outpatients with renal dysfunction.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2014

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Acute coronary syndromes; Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 May 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 23 Jan 2008 The expected completion date for this trial is now 1 Aug 2008.
    • 31 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top